Latest filings (excl ownership)
8-K
Immunocore reports first quarter financial results and provides a business update
8 May 24
10-Q
2024 Q1
Quarterly report
8 May 24
ARS
2023 FY
Annual report to shareholders
12 Apr 24
DEF 14A
Definitive proxy
12 Apr 24
8-K
Other Events
5 Apr 24
424B7
Prospectus with selling stockholder info
5 Apr 24
PRE 14A
Preliminary proxy
2 Apr 24
S-8
Registration of securities for employees
20 Mar 24
S-3ASR
Automatic shelf registration
20 Mar 24
8-K
Immunocore reports fourth quarter and full year 2023 financial results and provides a business update
28 Feb 24
10-K
2023 FY
Annual report
28 Feb 24
8-K
Immunocore Prices Upsized Convertible Senior Notes Offering
2 Feb 24
8-K
Immunocore Announces Proposed Convertible Senior Notes Offering
29 Jan 24
8-K
Immunocore announces strategic priorities and pipeline expansion ahead of 42nd Annual J.P. Morgan Healthcare Conference presentation
5 Jan 24
8-K
Regulation FD Disclosure
2 Jan 24
6-K
Current report (foreign)
7 Nov 23
6-K
Current report (foreign)
10 Aug 23
6-K
Current report (foreign)
14 Jul 23
6-K
Immunocore presents additional ctDNA data from the KIMMTRAK Phase 3 trial at ASCO
5 Jun 23
6-K
Current report (foreign)
16 May 23
6-K
Current report (foreign)
10 May 23
6-K
Immunocore presents new KIMMTRAK data confirming association between early ctDNA reduction and longer overall survival
18 Apr 23
6-K
Current report (foreign)
18 Apr 23
S-8
Registration of securities for employees
6 Apr 23
6-K
Current report (foreign)
10 Mar 23
6-K
Current report (foreign)
2 Mar 23
20-F
2022 FY
Annual report (foreign)
1 Mar 23
6-K
Immunocore Reports 2022 Financial Results and Provides Business Update
1 Mar 23
6-K
Immunocore announces initial Phase 1 safety and pharmacodynamic activity data with first soluble TCR therapy for people living with HIV
22 Feb 23
6-K
Current report (foreign)
11 Jan 23
6-K
Immunocore announces strategic priorities including pipeline expansion for 2023 -2024
9 Jan 23
6-K
Immunocore presents ovarian cancer expansion data for ImmTAC® candidate IMC-C103C targeting MAGE-A4
8 Dec 22
6-K
Immunocore and Gadeta Announce Agreement to Develop First Gamma Delta (γδ) TCR ImmTAC for Solid Tumors
2 Dec 22
6-K/A
Index to Unaudited Condensed Consolidated Interim Financial Statements
18 Nov 22
6-K
Immunocore presents new biomarker analysis for KIMMTRAK (tebentafusp-tebn) in metastatic uveal melanoma at the SITC 2022 Annual Meeting
14 Nov 22
6-K
Index to Unaudited Condensed Consolidated Interim Financial Statements
9 Nov 22
6-K
Current report (foreign)
30 Sep 22
424B7
Prospectus with selling stockholder info
30 Sep 22
6-K
Cautionary Note Regarding Forward Looking Statements
9 Sep 22
424B5
Prospectus supplement for primary offering
9 Sep 22
Latest ownership filings
4
Leger Tina Amber St
3 Apr 24
144
Notice of proposed sale of securities
1 Apr 24
SC 13G
FMR LLC
11 Mar 24
SC 13D/A
GENERAL ATLANTIC, L.P.
7 Mar 24
4
David M Berman
1 Mar 24
4
David M Berman
28 Feb 24
144
Notice of proposed sale of securities
26 Feb 24
4
Leger Tina Amber St
21 Feb 24
4
Donato Brian Di
21 Feb 24
4
JOHN GOLL
21 Feb 24
4
David M Berman
21 Feb 24
4
Bahija Jallal
21 Feb 24
SC 13G/A
Rock Springs Capital Management LP
14 Feb 24
SC 13G
PRICE T ROWE ASSOCIATES INC /MD/
14 Feb 24
SC 13G/A
RTW INVESTMENTS, LP
14 Feb 24
SC 13G
WELLINGTON MANAGEMENT GROUP LLP
8 Feb 24
SC 13G/A
WELLINGTON MANAGEMENT GROUP LLP
6 Feb 24
SC 13D/A
BAKER BROS. ADVISORS LP
1 Feb 24
4
Leger Tina Amber St
5 Jan 24
144
Notice of proposed sale of securities
3 Jan 24
3
Leger Tina Amber St
2 Jan 24
3
Peter John Ratcliffe
2 Jan 24
3
Kristine Peterson
2 Jan 24
3
ROBERT J PEREZ
2 Jan 24
3
Siddharth Kaul
2 Jan 24
3
Bahija Jallal
2 Jan 24
3
Roy Steven Herbst
2 Jan 24
3
JOHN GOLL
2 Jan 24
3
Travis Alan Coy
2 Jan 24
3
David M Berman
2 Jan 24
3
John Irving Bell
2 Jan 24
3
Donato Brian Di
2 Jan 24
144
Notice of proposed sale of securities
27 Dec 23
144
Notice of proposed sale of securities
20 Dec 23
144
Notice of proposed sale of securities
30 Nov 23
144
Notice of proposed sale of securities
16 Nov 23
144
Notice of proposed sale of securities
6 Nov 23
144
Notice of proposed sale of securities
2 Oct 23
SC 13D/A
GENERAL ATLANTIC, L.P.
18 Sep 23
144
Notice of proposed sale of securities
25 Aug 23